Please login to the form below

Not currently logged in
Email:
Password:

medicines value

This page shows the latest medicines value news and features for those working in and with pharma, biotech and healthcare.

Who's calling the shots in European healthcare?

Who's calling the shots in European healthcare?

Natsis believes this is a pointer to the future direction of medicines pricing and reimbursement in Europe. ... PME: How do Europe’s healthcare systems need to evolve? EFPIA:Our current system means the costs are borne in year one from the medicines

Latest news

More from news
Approximately 2 fully matching, plus 126 partially matching documents found.

Latest Intelligence

  • Risks, reforms and rewards: the evolving Russian healthcare market Risks, reforms and rewards: the evolving Russian healthcare market

    In contrast, the value of medicines bought by the commercial or private healthcare sector was 991bn roubles in 2018, up from 948bn the previous year. ... The Russian market is dominated by generic drugs. Only 14.4% of medicines sold in the country in

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    We brought a lot of innovative new medicines to patients there, which involved intensive work in educating healthcare professionals and the government about the value of innovation in pharma.”. ... That means we need to have a discussion around value,

  • The first, my last, my everything The first, my last, my everything

    This growing empowerment arguably has its biggest impact in the arena of high-value medicines. ... The patient voice is increasingly being used to influence payers and encourage them to support high-value medicines.

  • The Orkambi blame game The Orkambi blame game

    on the cost and value of the drug, which has a list price of £104, 000 ($136, 000) per patient per year. ... is to capture the full value of specialist medicines for small populations.

  • #OrkambiNow? #OrkambiNow?

    per patient per year price – comparable to the cost of older and less effective CF medicines such as Pulmozyme. ... New models urgently needed. It’s widely acknowledged that healthcare systems and the industry need to converge around new models,

More from intelligence
Approximately 1 fully matching, plus 45 partially matching documents found.

Latest appointments

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    grow this company into a very excising and meaningful entity that has the potential to create both important new medicines for patients and generate significant value for shareholders.".

  • Sanofi appoints Dr Yong-Jun Liu as head of research Sanofi appoints Dr Yong-Jun Liu as head of research

    April. In his new role, Dr Liu will be responsible for all of the Paris-based pharmaceutical company's research and will be tasked with delivering innovative and high-value medicines.

  • ABPI Scotland appoints Sandra Auld as director ABPI Scotland appoints Sandra Auld as director

    the access to and use of new and innovative medicines for Scottish patients. . ... The ABPI Scotland team is fully committed to working with all of our stakeholders to support a common understanding and appreciation of the life-saving and life-enhancing

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of animators and science experts creating photo real life-science animation content for the healthcare and...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics